Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Wong

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Stroke|June 20, 2018
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES TrialK S Lawrence Wong, Pierre Amarenco, Gregory W Albers, et al.
Circulation|June 29, 2017
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J Donald Easton, Maria Aunes, Gregory W Albers, et al.
Neurology|May 10, 2015
Prevalence, knowledge, and treatment of transient ischemic attacks in ChinaYilong Wang, Xingquan Zhao, Yong Jiang, et al.
The Lancet. Neurology|February 28, 2017
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trialPierre Amarenco, Gregory W Albers, Hans Denison, et al.
Stroke|July 20, 2017
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined SourcePierre Amarenco, Gregory W Albers, Hans Denison, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 18, 2017
Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia NetworkYook-Chin Chia, Peera Buranakitjaroen, Chen-Huan Chen, et al.
Stroke|April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trialKa Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 17, 2018
Guidance on home blood pressure monitoring: A statement of the HOPE Asia NetworkKazuomi Kario, Sungha Park, Peera Buranakitjaroen, et al.
Stroke|December 25, 2010
Determinants of quality of life after stroke in China: the ChinaQUEST (QUality Evaluation of Stroke care and Treatment) studyCandice Delcourt, Maree Hackett, Yanfeng Wu, et al.
Neurorehabilitation and Neural Repair|February 29, 2012
Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trialRaymond L Rosales, Keng He Kong, Khean Jin Goh, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Stroke|June 20, 2018
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES TrialK S Lawrence Wong, Pierre Amarenco, Gregory W Albers, et al.
Circulation|June 29, 2017
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J Donald Easton, Maria Aunes, Gregory W Albers, et al.
Neurology|May 10, 2015
Prevalence, knowledge, and treatment of transient ischemic attacks in ChinaYilong Wang, Xingquan Zhao, Yong Jiang, et al.
The Lancet. Neurology|February 28, 2017
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trialPierre Amarenco, Gregory W Albers, Hans Denison, et al.
Stroke|July 20, 2017
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined SourcePierre Amarenco, Gregory W Albers, Hans Denison, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 18, 2017
Current status of home blood pressure monitoring in Asia: Statement from the HOPE Asia NetworkYook-Chin Chia, Peera Buranakitjaroen, Chen-Huan Chen, et al.
Stroke|April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trialKa Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|February 17, 2018
Guidance on home blood pressure monitoring: A statement of the HOPE Asia NetworkKazuomi Kario, Sungha Park, Peera Buranakitjaroen, et al.
Stroke|December 25, 2010
Determinants of quality of life after stroke in China: the ChinaQUEST (QUality Evaluation of Stroke care and Treatment) studyCandice Delcourt, Maree Hackett, Yanfeng Wu, et al.
Neurorehabilitation and Neural Repair|February 29, 2012
Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trialRaymond L Rosales, Keng He Kong, Khean Jin Goh, et al.
Pageof 10